Background About 30% of the cervical cancer cases in Sweden occur in women older than 60. The primary aim was to evaluate the acceptability of repeated self-sampling at home for HPV-testing in elderly women. The prevalence of HPV and HPV related dysplasia as well as the sensitivity of cytology was evaluated. Methods Repeated self-sampling at home for HPV testing was offered 375 women in each of the four age groups 60, 65, 70 and 75 years. Women with two consecutive positive HPV tests were examined with sampling for histology and cytology. Findings A self-sample was provided by 59.5% (893/1500) of the invited women. The overall prevalence of HPV was 4.4% (95% CI 3.2-6.0, n = 39) in the first test, and 2.5% were persistent positive in the sec...
Since the introduction of organized cytological screening in Sweden, most women currently presenting...
Cervical cancer is preventable through gynecological screening. To promote participation among non-a...
AbstractIn France, about 40% of women aged 25–65 years do not participate in regular screening and t...
Background About 30% of the cervical cancer cases in Sweden occur in women older than 60. The primar...
BackgroundAbout 30% of the cervical cancer cases in Sweden occur in women older than 60. The primary...
In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cases occur in wo...
Introduction: In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cas...
Background: About one-third of the cervical cancer cases in Sweden occur in women over the age of 60...
Background Self-sampling for HPV testing, as an alternative to the conventional speculum based sampl...
BACKGROUND:About one-third of the cervical cancer cases in Sweden occur in women over the age of 60....
BACKGROUND: Self-sampling for HPV testing, as an alternative to the conventional speculum based samp...
BACKGROUND/AIM: Cervical cancer is associated with poorer diagnosis among the elderly and pap-smear ...
Purpose: Cervical cancer prevention for older women can be challenging since there are no specific g...
Objectives HPV self-sampling is an option for cervical screening. The aim of this randomised study w...
AimMany cervical cancers occurs among women over 65 and prevalence of HPV genotypes in this age coho...
Since the introduction of organized cytological screening in Sweden, most women currently presenting...
Cervical cancer is preventable through gynecological screening. To promote participation among non-a...
AbstractIn France, about 40% of women aged 25–65 years do not participate in regular screening and t...
Background About 30% of the cervical cancer cases in Sweden occur in women older than 60. The primar...
BackgroundAbout 30% of the cervical cancer cases in Sweden occur in women older than 60. The primary...
In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cases occur in wo...
Introduction: In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cas...
Background: About one-third of the cervical cancer cases in Sweden occur in women over the age of 60...
Background Self-sampling for HPV testing, as an alternative to the conventional speculum based sampl...
BACKGROUND:About one-third of the cervical cancer cases in Sweden occur in women over the age of 60....
BACKGROUND: Self-sampling for HPV testing, as an alternative to the conventional speculum based samp...
BACKGROUND/AIM: Cervical cancer is associated with poorer diagnosis among the elderly and pap-smear ...
Purpose: Cervical cancer prevention for older women can be challenging since there are no specific g...
Objectives HPV self-sampling is an option for cervical screening. The aim of this randomised study w...
AimMany cervical cancers occurs among women over 65 and prevalence of HPV genotypes in this age coho...
Since the introduction of organized cytological screening in Sweden, most women currently presenting...
Cervical cancer is preventable through gynecological screening. To promote participation among non-a...
AbstractIn France, about 40% of women aged 25–65 years do not participate in regular screening and t...